CSP-2503
CSP-2503 is a potent and selective 5-HT1A receptor agonist, 5-HT2A receptor antagonist, and 5-HT3 receptor antagonist of the phenylpiperazine class. First synthesized in 2003, it was designed based on computational models and QSAR studies. In rat studies, CSP-2503 has demonstrated anxiolytic effects, and thus has been suggested as a treatment for anxiety in humans with a multimodal mechanism of action.
Wikipage redirect
primaryTopic
CSP-2503
CSP-2503 is a potent and selective 5-HT1A receptor agonist, 5-HT2A receptor antagonist, and 5-HT3 receptor antagonist of the phenylpiperazine class. First synthesized in 2003, it was designed based on computational models and QSAR studies. In rat studies, CSP-2503 has demonstrated anxiolytic effects, and thus has been suggested as a treatment for anxiety in humans with a multimodal mechanism of action.
has abstract
CSP-2503 is a potent and selec ...... ultimodal mechanism of action.
@en
ATC prefix
IUPAC name
2-[(4-naphthalen-1-ylpiperazin-1-yl)methyl]hexahydropyrrolo[1,2-a]pyrazine-1,4-dione
@en
PubChem
thumbnail
Wikipage page ID
28,480,622
Wikipage revision ID
722,523,259
ChEMBL
ChemSpiderID
molecular weight
smiles
O=C4N5CCCC5CNC4
StdInChIKey
CTZWGZSINBFHFD-UHFFFAOYSA-N
verifiedrevid
414,040,667
hypernym
comment
CSP-2503 is a potent and selec ...... ultimodal mechanism of action.
@en
label
CSP-2503
@en